Recently, I overheard a conversation between two seniors in front of the checkout at a Korean market. One said, "I heard Wegovy is $50 with Medicare," and the other replied, "But I heard not everyone qualifies for that."

Curious, I dug into the CMS materials myself. To cut to the chase, both of them are correct.

The program is called Medicare GLP-1 Bridge. It started on July 1, 2026, and will run until December 31, 2027.

Originally, Medicare Part D is legally prohibited from covering weight loss medications. Therefore, GLP-1s intended solely for obesity treatment have been effectively out-of-pocket expenses until now.

The Bridge is a pilot program that temporarily fills this gap. It was initially planned to transition to a follow-up program called the BALANCE model, but that has been delayed, resulting in a one-year extension for the Bridge.

There are exactly three eligible medications: Wegovy injections and pills, the pill form of Foundayo, and Zepbound, but only in the KwikPen formulation.

Single-use pens or vials of Zepbound are not eligible. This is why it's important to confirm the formulation when getting a prescription.

The out-of-pocket cost is a flat $50 for a month's supply. Honestly, it's quite remarkable that the price remains the same even if the dosage increases.

Now, let's talk about the eligibility criteria. Most people get stuck here.

First, you must be at least 18 years old and have Medicare prescription insurance, Part D. Without prescription insurance, you can't even start.

If your BMI is 35 or higher, that alone qualifies you. It's the simplest case.

If your BMI is between 30 and 34.9, you need to have one of the following: advanced heart failure, uncontrolled hypertension, or chronic kidney disease stage 3 or higher.

If your BMI is between 27 and 29.9, you need to have prediabetes, a history of heart attack or stroke, or symptomatic peripheral artery disease.

Interestingly, if you have type 2 diabetes, you are actually excluded from the Bridge eligibility. At first, I wondered what the logic behind this was.

The reason is simple. Diabetes, moderate to severe sleep apnea, and fatty liver disease (MASH) are already indications for receiving GLP-1 through regular Part D, so they direct you to that route.

Prior authorization is also mandatory. Your doctor must confirm that the prescription is part of a lifestyle management plan that includes diet and exercise.

The process works like this: when the pharmacy submits a claim, it goes through a central processing agency, and typically within 24 to 72 hours, a prior authorization request is sent to the doctor.

The pharmacy may ask for your Medicare number or the last four digits of your SSN. Don't panic; just make sure to bring your card with you.

You also need to check the type of plan. Whether it's Original Medicare or Medicare Advantage, it must include Part D, but there are some types like PACE or certain cost plans that are excluded.

This is where I want to highlight a real pitfall. This $50 does not count towards the Part D deductible or the annual out-of-pocket maximum of $2,100 for 2026.

If you have many other medication costs, that means an additional $600 a year is going out of pocket beyond the cap. It won't even show up on your Part D statement.

What's even more disappointing is that those receiving low-income assistance, like Extra Help, still have to pay the full $50. For someone whose usual medication costs are just a few dollars, $50 a month is not a small amount.

According to KFF analysis, as of 2023, the number of people who meet all the criteria is just under 3.8 million, which is 8% of Part D enrollees. This is only 29% of the 13.3 million people who are obese or overweight.

In the same analysis, the net cost to Medicare per person was estimated at $245 a month. It's not a light investment from the government's perspective either.

Personally, I believe the direction is correct. Treating obesity as a chronic condition that requires management rather than a matter of willpower is the right trend.

However, I think the structure that low-income assistance doesn't apply is somewhat backward. It's designed to be the heaviest burden on those who need the most help.

So what should you do? First, check your recent BMI and diagnosis, and ask your primary care physician if you can get prior authorization for the Bridge.

Next, check the formulation. If it's Zepbound, confirm that it's the KwikPen, and also call your plan to verify that it includes Part D.

If you're in California, there's also a free Medicare counseling service called HICAP. When you're confused about plan types, asking them is the quickest way to get answers.

Side effects and eligibility can vary from person to person, so be sure to consult with your doctor or pharmacist before starting.

In summary, the $50 a month is definitely an opportunity. However, it's temporary until the end of 2027 and has strict conditions, so if I were you, I would check my eligibility before the end of the year.